Spectrophotometric determination of H2-receptor antagonists via their oxidation with cerium(IV)

被引:44
作者
Darwish, Ibrahim A. [1 ]
Hussein, Samiha A. [1 ]
Mahmoud, Ashraf M. [1 ]
Hassan, Ahmed I. [2 ]
机构
[1] Assiut Univ, Fac Pharm, Dept Pharmaceut Analyt Chem, Assiut 71526, Egypt
[2] Al Azhar Univ, Fac Pharm, Dept Pharmaceut Analyt Chem, Assiut 71524, Egypt
关键词
H-2-receptors antagonists; cerium(IV); spectrophotometry; pharmaceutical analysis;
D O I
10.1016/j.saa.2007.03.005
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
A simple, accurate and sensitive spectrophotometric method has been developed and validated for determination of H-2-receptor antagonists: cimetidine, famotidine, nizatidine and ranitidine hydrochloride. The method was based on the oxidation of these drugs with cerium(IV) in presence of perchloric acid and subsequent measurement of the excess Ce(IV) by its reaction with p-dimethylaminobenzaldehyde to give a red colored product (lambda(max) at 464 nm). The decrease in the absorption intensity of the colored product (Delta A), due to the presence of the drug was correlated with its concentration in the sample solution. Different variables affecting the reaction were carefully studied and optimized. Under the optimum conditions, linear relationships with good correlation coefficients (0.9990-0.9994) were found between Delta A values and the concentrations of the drugs in a concentration range of 1-20 mu g ml(-1). The assay limits of detection and quantitation were 0.18-0.60 and 0.54-1.53 mu g ml(-1), respectively. The method was validated, in terms of accuracy, precision, ruggedness and robustness; the results were satisfactory. The proposed method was successfully applied to the determination of the investigated drugs in pure and pharmaceutical dosage forms (recovery was 98.3-102.6 +/- 0.57-1.90%) without interference from the common excipients. The results obtained by the proposed method were comparable with those obtained by the official methods. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:33 / 40
页数:8
相关论文
共 39 条
[11]  
Darwish IA, 2006, J AOAC INT, V89, P341
[12]   Kinetic spectrophotometric methods for determination of trimetazidine dihydrochloride [J].
Darwish, IA .
ANALYTICA CHIMICA ACTA, 2005, 551 (1-2) :222-231
[13]   QUANTITATIVE SPECTROPHOTOMETRIC DETERMINATION OF HYDROGEN PEROXIDE WITH PARA-DIMETHYLAMINOBENZALDEHYDE [J].
DASGUPTA, BR ;
BOROFF, DA .
ANALYTICAL CHEMISTRY, 1968, 40 (13) :2060-&
[14]  
DOLLERY C, 1999, TXB THERAPEUTIC DRUG, V1, pC215
[15]   Stability indicating spectrodensitometric determination of ranitidine hydrochloride using linear and non-linear regression [J].
El-Bayoumi, AEA ;
El-Shanawany, A ;
El-Sadek, ME ;
El-Sattar, AA .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 21 (04) :867-873
[16]   Spectrophotometric and titrimetric determination of nizatidine in capsules [J].
El-Yazbi, FA ;
Gazy, AA ;
Mahgoub, H ;
El-Sayed, MA ;
Youssef, RM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 31 (05) :1027-1034
[17]   Synchronous spectrofluorimetric determination of famotidine, fluconazole and ketoconazole in bulk powder and in pharmaceutical dosage forms [J].
ElBayoumi, A ;
ElShanawany, AA ;
ElSadek, ME ;
AbdElSattar, A .
SPECTROSCOPY LETTERS, 1997, 30 (01) :25-46
[18]  
GENDY AE, 2001, SPECTROSC LETT, V34, P221
[19]   Kinetic spectrophotometric determination of nizatidine and ranitidine in pharmaceutical preparations [J].
Hassan, EM ;
Belal, F .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 27 (1-2) :31-38
[20]  
*HER MAJ STAT OFF, 1998, BRIT PHARM